Concord Wealth Partners boosted its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 7.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,562 shares of the healthcare conglomerate’s stock after acquiring an additional 502 shares during the quarter. Concord Wealth Partners’ holdings in UnitedHealth Group were worth $3,825,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. State Street Corp lifted its stake in shares of UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after purchasing an additional 563,554 shares in the last quarter. Geode Capital Management LLC grew its position in UnitedHealth Group by 1.6% in the third quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after acquiring an additional 318,039 shares in the last quarter. Franklin Resources Inc. lifted its position in shares of UnitedHealth Group by 2.5% during the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after purchasing an additional 193,800 shares in the last quarter. International Assets Investment Management LLC increased its stake in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after buying an additional 5,290,025 shares during the period. Finally, Fisher Asset Management LLC boosted its position in UnitedHealth Group by 3.5% in the 3rd quarter. Fisher Asset Management LLC now owns 3,197,167 shares of the healthcare conglomerate’s stock valued at $1,869,320,000 after buying an additional 107,097 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Trading Down 0.6 %
Shares of UNH stock opened at $542.30 on Friday. The firm has a market capitalization of $499.07 billion, a PE ratio of 34.99, a price-to-earnings-growth ratio of 1.46 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a fifty day moving average of $536.17 and a two-hundred day moving average of $565.14.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.
Insider Activity
In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.33% of the company’s stock.
Analysts Set New Price Targets
UNH has been the subject of a number of analyst reports. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Oppenheimer lifted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Bank of America decreased their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Finally, UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $629.32.
Read Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- What is Put Option Volume?
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- What is a Secondary Public Offering? What Investors Need to Know
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- MarketBeat Week in Review – 01/27 – 01/31
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.